Inhibition of Bcl-2/Bax/cleaved caspase-3 pathway activity by rare ginsenosides ameliorates cyclophosphamide-induced oligoasthenospermia (OA) in male mice
Bibliographic Data
| ID | 14734454 |
|---|---|
| Authors | Fei Yan (0000-0001-7477-5990, Weifang Medical University), Jiamin Li (0000-0002-6443-1710, Weifang Medical University), Murong Zhu, Mingyao Zhu (0000-0001-6665-8348, Weifang Medical University), Ke Zhao (0000-0002-9974-4901, Weifang Medical University), Jiasheng Han (82th Hospital of Pla), Yan Wang (0009-0009-9633-0023, Weifang Medical University), Lei Fang (0000-0002-2582-4845, Weifang Medical University, corresponding author), Peng Xue (0000-0002-0681-1176, Weifang Medical University, corresponding author) |
| Year | 2025 |
| Volume | 353 |
| Issue | Pt A |
| Pages | 120378 |
| Publication date | 2025-09-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ethnopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2025.120378 |
| PMID | 40769435 |
| OpenAlex | W4413013551 |
| Language | EN |
| Citations received | 2 |
| References cited | 36 |
Apoptosis · Caspase · Caspase 3 · Chemotherapy · Cyclophosphamide · Programmed cell death · Traditional medicine · Autophagy in Disease and Therapy · Chemistry · Ginseng Biological Effects and Applications · Lipid metabolism and disorders · Medicine · Biochemistry · Internal Medicine · Pharmacology
Investigating the effects of rare ginsenosides on hyperuricemia and associated sperm damage via nontargeted metabolomics and gut microbiota
Comparative studies on the chemical composition and pharmacological effects of vinegar-processed antler glue modified from Lei Gong Pao Zhi Lun and traditional water-processed antler glue
Inhibition of p38 Mapk/NF-κB p65 signaling pathway activity by rare ginsenosides ameliorates cyclophosphamide-induced premature ovarian failure and KGN cell injury
| Unique citing works | 2 |
|---|---|
| Citations per year | 2 |
| Citation span | 2026 - 2027 (2) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 2 |